Episode 186: Building Your Resilience with Dr. Meghan Beier
RealTalk MS22 Maalis 2021

Episode 186: Building Your Resilience with Dr. Meghan Beier

Living through a lockdown can be challenging, and it's resilience that helps us get through life's challenges and recover from setbacks. And while resilience may have become a new topic of conversation for the world at large, when you're living with the uncertainty of MS, you come to realize that resilience is one of the most important tools in your self-care toolbox.

Joining me to talk about building your resilience is Dr. Meghan Beier. Dr. Beier is a Rehabilitation Neuropsychologist and an Assistant Professor of Physical Medicine at the Johns Hopkins University School of Medicine, where she specializes in cognitive rehabilitation and neuropsychological assessment and intervention.

We'll also share the National MS Society's Vaccine Advisory Group's updated vaccine guidance for people living with MS.

We'll tell you about the new oral disease-modifying therapy that just received FDA approval.

You'll hear about the newly-announced partnership between the MS Society and Park Health, and we'll explain how this partnership will deliver personalized one-to-one health coaching to help people live better with MS.

And we'll tell you about the entrepreneur who won the Lyfebulb Bristol Myers Squibb MS Innovation Challenge by setting out to resolve one of his father's most bothersome MS symptoms.

We have a lot to talk about! Are you ready for RealTalk MS??!

National MS Society's Vaccine Advisory Group announces updated guidance for people living with MS 2:03

Here's your chance to participate in COVID-19 & MS research 4:32

Ponesimod receives FDA approval 5:29

National MS Society announces partnership with Park Health 6:24

Evolution Devices wins Lyfebulb Bristol Myers Squibb Innovation Challenge 8:18

My interview with Dr. Meghan Beier 11:19

Share this episode 25:35

Take the RealTalk MS Listener Survey and you could win a $100 Amazon Gift Card 25:54

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/186

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

RealTalk MS Listener Survey (You'll be entered to win a $100 Amazon Gift Card!)

National MS Society COVID-19 Vaccine Guidance for People Living with MS

COVID-19 Studies Recruiting People with MS

Evolution Devices

CAN-DO MS Program Information and Registration

Join the WalkMS RealTalk MS RealWalkers Team

Join the RealTalk MS Facebook Group

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

Give RealTalk MS a Rating and Review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 186
Guests: Dr. Meghan Beier

Tags: MS, MultipleSclerosis, MSResearch, MSSociety, MSActivist, Resilience, COVIDVaccine, Lyfebulb, RealTalkMS

Privacy Policy

Jaksot(506)

Episode 444: Treating MS with a GLP-1 with Dr. Ellen Mowry

Episode 444: Treating MS with a GLP-1 with Dr. Ellen Mowry

You know them by their trade names such as Ozempic, Wegovy, Mounjaro, and Zepbound. This class of medications is known as GLP-1 receptor agonists. And while they are best known for managing diabetes a...

2 Maalis 31min

Episode 443: The 2026 ACTRIMS Forum (Part 3) with Dr. Helen Tremlett, Dr. Ilana Katz Sand, and Kathy Smith

Episode 443: The 2026 ACTRIMS Forum (Part 3) with Dr. Helen Tremlett, Dr. Ilana Katz Sand, and Kathy Smith

Welcome back to the third and final part of our coverage of the 2026 ACTRIMS Forum. This week's episode bridges the gap between groundbreaking clinical research and the nuanced reality of living with ...

23 Helmi 35min

Episode 442: The 2026 ACTRIMS Forum (Part 2) with Dr. Jeffrey Cohen, Dr. Daniel Ontaneda, and Kristine Werner Ozug

Episode 442: The 2026 ACTRIMS Forum (Part 2) with Dr. Jeffrey Cohen, Dr. Daniel Ontaneda, and Kristine Werner Ozug

Welcome back to Part Two of our coverage of the 2026 ACTRIMS Forum. This week, we shift our focus to emerging therapies and clinical insights that are re-shaping the future of MS care. From the latest...

16 Helmi 44min

Episode 441: The 2026 ACTRIMS Forum with Dr. Manuel Friese, Dr. Amit Bar-Or, and Dr. Haritha Desu

Episode 441: The 2026 ACTRIMS Forum with Dr. Manuel Friese, Dr. Amit Bar-Or, and Dr. Haritha Desu

Last week, over 1,400 scientists and clinicians gathered in San Diego, California, at the 2026 Americas Committee for Treatment and Research in Multiple Sclerosis annual meeting, better known as the A...

9 Helmi 33min

Episode 440: An MS Specialist's Response to the FDA with Dr. William Conte

Episode 440: An MS Specialist's Response to the FDA with Dr. William Conte

This past December, the FDA issued a Complete Response Letter to drug manufacturer Sanofi in response to Sanofi's application seeking approval for Tolebrutinib, the first in a new category of investig...

2 Helmi 39min

Episode 439: Preventing MS with Dr. Bruce Bebo

Episode 439: Preventing MS with Dr. Bruce Bebo

The first coordinated global research strategy to prevent MS has been announced. This week, Dr. Bruce Bebo, the National MS Society's Executive Vice President and Chief Research & Medical Affairs Offi...

26 Tammi 32min

Episode 438: The Discovery of 2 MS Subtypes with Dr. Arman Eshaghi

Episode 438: The Discovery of 2 MS Subtypes with Dr. Arman Eshaghi

One of the more confusing aspects of MS is that it can present differently from one person to the next. A research team at University College London may have uncovered a reason for that when they iden...

19 Tammi 29min

Episode 437: Remembering David Mitchell

Episode 437: Remembering David Mitchell

I don't have to remind anyone who listens to this podcast that the cost of MS disease-modifying therapies is obscenely high. And we're not just talking about relatively new medications. Older medicati...

12 Tammi 29min

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
tiedenaiset-podcast
psykopodiaa-podcast
voi-hyvin-meditaatiot-2
rss-pitaisko-erota
vakeva-elama-viisaampi-mieli-vahvempi-keho
rss-kuumilla-aalloilla
rss-kyykkya-ja-kuoharia
meditaatiot-suomeksi
puhu-muru
fitnessvastaanotto
rss-pt-paahtio
paaasia-podcast
selviytyjat-tarinoita-elamasta
rss-uplevel-by-sonja-hannus
rss-vapaudu-voimaasi
terapiassa
onnen-kuplia
rss-rakas-mielenterveyteni
paritellen